AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank67
3Y CAGR+31.0%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+31.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.94M | -9.2% |
| 2024 | $3.23M | -34.1% |
| 2023 | $4.90M | +275.4% |
| 2022 | $1.31M | +4112.9% |
| 2021 | $31000.00 | +100.5% |
| 2020 | $-6.32M | -130.5% |
| 2019 | $-2.74M | - |